IP Library Granted Patent US 11,560,582
Granted Patent B2
US 11,560,582 · App. 17/251,899 · Granted Jan 24, 2023

Fusion moieties and microbial hosts for protein production

Inventors: Peik Haugen (Kvaløysletta, NO); Miriam Grgic (Tromsø, NO); Jenny Johansson Söderberg (Tromsø, NO)
Assignee: UNIVERSITETET I TROMSØ—NORGES ARKTISKE UNIVERSITET
C12P21/02C12N9/16C12Y301/11001C07K2319/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,560,582
App. No.
17/251,899
Granted
Jan 24, 2023
Kind
B2
Abstract

The present invention relates to fusion proteins comprising (i) a fusion moiety based on SEQ ID NO:1 and (ii) a protein. Also provided are nucleic acids encoding such fusion proteins and compositions comprising such fusion proteins. The invention also provides a method for increasing the expression level of a protein in a host cell or increasing the level of secretion of a protein from a host cell, said methods employing a fusion moiety in accordance with the invention. The invention further provides a method of producing a protein, said method comprising culturing an Aliivibrio wodanis host cell comprising a heterologous nucleic acid molecule encoding a protein under conditions suitable for the expression of the encoded protein. Certain deposited strains of Aliivibrio wodanis are also provided.

Claims (29)

1. A nucleic acid molecule encoding a fusion protein comprising

(i) a fusion moiety comprising the amino acid sequence of SEQ ID NO:1 or an amino acid sequence that is at least 80% identical to SEQ ID NO:1; and

(ii) a protein.

2. A nucleic acid molecule encoding a fusion protein, said nucleic acid molecule comprising

(i) a polynucleotide comprising the polynucleotide sequence of SEQ ID NO:2 or SEQ ID NO:5, or a polynucleotide sequence that is at least 80% identical to SEQ ID NO:2 or SEQ ID NO:5; and

(ii) a polynucleotide encoding a protein.

3. A method of producing a protein, said method comprising culturing a host cell comprising a heterologous nucleic acid molecule encoding said protein under conditions suitable for the expression of the encoded protein, wherein said protein is a fusion protein comprising

(i) a fusion moiety comprising the amino acid sequence of SEQ ID NO:1 or SEQ ID NO:4 or an amino acid sequence that is at least 80% identical to SEQ ID NO:1 or SEQ ID NO:4, and

(ii) a protein.

4. The method of claim 3 , said method further comprising, subsequent to culturing the host cell, a step of isolating the protein from the host cell or from the growth medium or supernatant.

5. The method of claim 3 , wherein said host cell is an Aliivibrio wodanis host cell.

6. A method of producing a protein, said method comprising culturing an Aliivibrio wodanis host cell comprising a heterologous nucleic acid molecule encoding said protein under conditions suitable for the expression of the encoded protein, wherein said protein is a fusion protein comprising

(i) a fusion moiety comprising the amino acid sequence of SEQ ID NO:1 or an amino acid sequence that is at least 80% identical to SEQ ID NO:1; and

(ii) a protein.

7. The method of claim 6 , wherein said Aliivibrio wodanis is an Aliivibrio wodanis strain selected from the group consisting of:

(i) the Aliivibrio wodanis strain deposited under accession number ECACC 18050101;

(ii) the Aliivibrio wodanis strain deposited under accession number ECACC 18050102; and

(iii) an Aliivibrio wodanis strain having all the identifying characteristics of one or both of strains (i) and (ii).

8. The method of claim 6 , wherein the culturing is done at a temperature of 4° C. to 18° C.

9. The method of claim 6 , said method (i) further comprising, prior to culturing the Aliivibrio wodanis , a step of introducing said heterologous nucleic acid molecule encoding said protein into the Aliivibrio wodanis host cell or (ii) further comprising, subsequent to culturing the Aliivibrio wodanis , a step of isolating the protein from the Aliivibrio wodanis or from the growth medium or supernatant.

10. An Aliivibrio wodanis strain selected from the group consisting of:

(i) the Aliivibrio wodanis strain deposited under accession number ECACC 18050101;

(ii) the Aliivibrio wodanis strain deposited under accession number ECACC 18050102; and

(iii) an Aliivibrio wodanis strain having all the identifying characteristics of one or both of strains (i) and (ii),

wherein the Aliivibrio wodanis strain comprises a heterologous nucleic acid molecule encoding a protein.

11. The method of claim 6 , said method (i) further comprising, prior to culturing the Aliivibrio wodanis , a step of introducing said heterologous nucleic acid molecule encoding said protein into the Aliivibrio wodanis host cell and (ii) further comprising, subsequent to culturing the Aliivibrio wodanis , a step of isolating the protein from the Aliivibrio wodanis or from the growth medium or supernatant.

12. The method of claim 4 further comprising the step of formulating the protein into a composition including at least one additional component.

13. The method of claim 9 further comprising the step of formulating the protein into a composition including at least one additional component.

14. The method of claim 11 further comprising the step of formulating the protein into a composition including at least one additional component.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2020
From: HAUGEN, PEIK; GRGIC, MIRIAM; JOHANSSON SÖDERBERG, JENNY
To: UNIVERSITETET I TROMSØ - NORGES ARKTISKE UNIVERSITET
Reel/Frame 054632/0504 →
Priority Claims (1)
GB 1810016 · Jun 19, 2018 · national
Continuity (1)
Related Publication 20210130865A1 · May 6, 2021